Charles Russell Speechlys advises management on the sale of Emerging Markets Payments
Charles Russell Speechlys has acted as legal adviser to the management team of Emerging Markets Payments (EMP), the leading Africa and Middle East payments business, on the sale of EMP by Actis to Network International. Actis is the private equity firm which invests exclusively in Africa, Asia and Latin America and is a leading investor in growth markets with $7bn of funds under management. Network International is a leading provider of payment solutions in the Middle East, and is backed by Emirates NBD, and private equity houses, General Atlantic and Warburg Pincus.
Charles Russell Speechlys acted for management on the management warranty deed and assisted with the disclosure process in relation to the transaction, alongside Clifford Chance, who acted for Actis on the sale. Freshfields acted for Network International.
The transaction is subject to regulatory approvals.
Charles Gill, Chief Operating Officer of EMP commented “This was a complex process, with multiple bidders running in parallel, and management spread across six countries. I’m very grateful for the advice and support that Charles Russell Speechlys provided throughout. ”
Commenting on the transaction, Malcolm MacDougall, Partner and head of the Private Equity team at Charles Russell Speechlys, said:
“We are delighted to have advised the management team of Emerging Markets Payments on the sale, and to have assisted in achieving exchange of contracts on the deal. We look forward to working with management to bring the transaction to a successful completion. ”
The Charles Russell Speechlys team consisted of Malcolm MacDougall and Chris Manning.
News & Insights
Government provides welcome clarity for EMI option holders who have been furloughed
The proposed amendments will provide some clarity and address concerns regarding the consequences of furloughing EMI option holders.
Charles Russell Speechlys advises Transense Technologies Plc on iTrack technology transaction with Bridgestone Corporation
Transense Technologies Plc, the provider of sensor systems for the industrial, mining and transportation markets.
Charles Russell Speechlys advises Kreos and SVB on $70m private placement for AIM listed Mereo BioPharma Group plc
Mereo BioPharma is a clinical stage UK-based biopharmaceutical company listed on the AIM market of the LSE.